NCT03589833 2022-10-25
YISTAR
Peking Union Medical College Hospital
Phase 4 Completed
Clinical Trials
3 trialsNCT03449758 2022-04-28
SariPRO
Sanofi
Phase 4 Completed
NCT01283971 2014-02-10
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor
Hoffmann-La Roche
Phase 4 Terminated